伟思医疗：股价异常波动，25年前三季度营收3.26亿元

Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days in late December 2025 and early January 2026, but there are no undisclosed significant matters affecting its operations [1] Financial Performance - As of the end of 2025, the company's new brain-computer interface products are in the early stages of market cultivation and have not yet achieved large-scale sales, contributing limited revenue [1] - For the first three quarters of 2025, the company reported revenue of 326 million yuan, representing a year-on-year increase of 11.58% [1] - The net profit for the same period was 102 million yuan, reflecting a year-on-year growth of 30.68% [1] Investor Advisory - The company has reminded investors to be cautious and to consider risks when investing [1]